Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma
British Journal of Haematology (2015)
  • Ryan D. Cassaday, Fred Hutchinson Cancer Research Center
  • Philip A. Stevenson, Fred Hutchinson Cancer Research Center
  • Theodore A. Gooley, Fred Hutchinson Cancer Research Center
  • Thomas R. Chauncey, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Joseph Rajendran, University of Washington
  • Brian G. Till, Fred Hutchinson Cancer Research Center
  • Mary Philip, Fred Hutchinson Cancer Research Center
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • William I. Bensinger, Fred Hutchinson Cancer Research Center
  • Leona A. Holmberg, Fred Hutchinson Cancer Research Center
  • Andrei R. Shustov, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Stephen D. Smith, Fred Hutchinson Cancer Research Center
  • Edward N. Libby, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
January 12, 2015
DOI
10.1111/bjh.13773
Citation Information
Ryan D. Cassaday, Philip A. Stevenson, Theodore A. Gooley, Thomas R. Chauncey, et al.. "High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma" British Journal of Haematology Vol. 171 Iss. 5 (2015) p. 788 - 797
Available at: http://works.bepress.com/john-pagel/73/